Literature DB >> 34219017

Determining the prevalence and risk factors for prescription drug unaffordability.

N S Donnenberg1, I Hernandez2, D P Normolle3.   

Abstract

BACKGROUND: Prescription affordability is a key component of healthcare accessibility and a determinant of health outcomes. Prior studies indicate that up to 1 in 4 Americans report difficulty affording prescriptions. OBJECTIVE(S): This study aims to identify factors associated with cost-based prescription refusal.
METHODS: We identified 17,869 study participants from the 2017 National Health Interview Survey who had been prescribed at least one medication in the past 12 months. The outcome was defined as inability to afford at least one prescription medication. Covariates included demographic data, medical history, and social attitudes. Logistic regression models were constructed to identify predictors of cost-based prescription refusal.
RESULTS: Among 8223 study participants, 8.1% reported the inability to afford at least one prescription medication in the past 12 months. Twenty-seven covariates were correlated with prescription unaffordability, and 8 were selected by the LASSO: Income (Odds ratio (OR) 0.55), Concerned About Bills (OR 2.0), Emergency Department Visits past 12 months (OR 1.33), Dissatisfaction with Medical Care (OR 1.3), Seeking Insurance Through the Health Insurance Marketplace (OR 1.26), Feeling Sad Most of the Time (OR 1.24), History of Asthma (OR 1.26) and History of Diabetes (OR 1.24).
CONCLUSIONS: Prescription unaffordability remains a significant public health problem and is more common among low-income individuals and patients with, chronic medical conditions.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Drug affordability; LASSO; Machine learning; Medication nonadherence; National health interview survey; Pharmacoeconomics

Mesh:

Substances:

Year:  2021        PMID: 34219017      PMCID: PMC8714864          DOI: 10.1016/j.sapharm.2021.06.019

Source DB:  PubMed          Journal:  Res Social Adm Pharm        ISSN: 1551-7411


  15 in total

1.  Drug affordability and prescription noncompliance in the United States: 1997-2002.

Authors:  Jae Kennedy; Joseph Coyne; David Sclar
Journal:  Clin Ther       Date:  2004-04       Impact factor: 3.393

Review 2.  The social determinants of health: it's time to consider the causes of the causes.

Authors:  Paula Braveman; Laura Gottlieb
Journal:  Public Health Rep       Date:  2014 Jan-Feb       Impact factor: 2.792

3.  Cost-Related Insulin Underuse Among Patients With Diabetes.

Authors:  Darby Herkert; Pavithra Vijayakumar; Jing Luo; Jeremy I Schwartz; Tracy L Rabin; Eunice DeFilippo; Kasia J Lipska
Journal:  JAMA Intern Med       Date:  2019-01-01       Impact factor: 21.873

4.  Income is an independent risk factor for worse asthma outcomes.

Authors:  Juan Carlos Cardet; Margee Louisias; Tonya S King; Mario Castro; Christopher D Codispoti; Ryan Dunn; Linda Engle; B Louise Giles; Fernando Holguin; John J Lima; Dayna Long; Njira Lugogo; Sharmilee Nyenhuis; Victor E Ortega; Sima Ramratnam; Michael E Wechsler; Elliot Israel; Wanda Phipatanakul
Journal:  J Allergy Clin Immunol       Date:  2017-05-20       Impact factor: 10.793

5.  Effects of innovation and insurance coverage on price elasticity of demand for prescription drugs: some empirical lessons in pharmacoeconomics.

Authors:  Roger Lee Mendoza
Journal:  J Med Econ       Date:  2020-06-25       Impact factor: 2.448

6.  The Economic Burden of Asthma in the United States, 2008-2013.

Authors:  Tursynbek Nurmagambetov; Robin Kuwahara; Paul Garbe
Journal:  Ann Am Thorac Soc       Date:  2018-03

7.  Increased Use Of Prescription Drugs Reduces Medical Costs In Medicaid Populations.

Authors:  M Christopher Roebuck; J Samantha Dougherty; Robert Kaestner; Laura M Miller
Journal:  Health Aff (Millwood)       Date:  2015-09       Impact factor: 6.301

Review 8.  Prescription drug insurance coverage and patient health outcomes: a systematic review.

Authors:  Aaron S Kesselheim; Krista F Huybrechts; Niteesh K Choudhry; Lisa A Fulchino; Danielle L Isaman; Mary K Kowal; Troyen A Brennan
Journal:  Am J Public Health       Date:  2015-02       Impact factor: 9.308

9.  Effect of prescription copayments on adherence and treatment failure with oral antidiabetic medications.

Authors:  John Barron; Peter Wahl; Maxine Fisher; Craig Plauschinat
Journal:  P T       Date:  2008-09

10.  Determinants of adherence to diabetes medications: findings from a large pharmacy claims database.

Authors:  M Sue Kirkman; Megan T Rowan-Martin; Rebecca Levin; Vivian A Fonseca; Julie A Schmittdiel; William H Herman; Ronald E Aubert
Journal:  Diabetes Care       Date:  2015-01-08       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.